1. The aim of this study was to determine the pattern of protein carboxymethylation in different regions of the human brain. 2. The availability of protein methylation sites was determined by measurement of the incorporation of methyl-JH groups into proteins isolated from postmortem brain time. The stability of protein carboxymethylation in post-mortem brain was determined by sampling post-mortem pig and human brain tissue at intervals during the b t 24 h after death. This method has previously been used to demonstrate that decreased protein carboxymethylation occurred in post-mortem pig brain when methionine synthase was inhibited. 3. There were no significant difierences in the protein carboxymethyltransferase activity in samples of pig brain obtained at the time of death compared with that obtained when the same tissue was maintained at room temperature for up to 24 h after death. Similarly, there were no significant differences in the protein carboxymethyltramferase activity in samples isolated from human brain 12 h after death compared with that obtained from the same human brain tissue maintained at room temperature for up to 24 h after death. These results suggest that the level of carboxymethylation of proteins from human post-mortem brain obtained within 24 h of death is not significantly Merent to the level present at the time of death. To characterize the distribution of protein carboxymethylation in human brain, nine regions of post-mortem brain were sampled from 16 human subjects. Protein carboxymethyltransferase activity was lowest in the cerebellum (P < 0.05) and highest in cortical white matter compared with other The aim of this study was to demonstrate the feasibility of measuring the level of protein carboxymethylation in post-mortem human brain tissue as a surrogate measurement of its level at the time of death. It also enabled us to determine the level of protein carboxymethylation in different regions of the human brain.
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I N T R O D U C T I O N
In the brain, abnormalities of methylation have been implicated in the pathogenesis of several diseases [1] [2] [3] [4] [5] [6] . Brain constituents such as myelin basic protein, creatine and phosphatidylcholine require methylation . Protein carboxymethylation is known to regulate the activity of membrane-bound molecules such as ras [ 101. The carboxymethylation of L-isoaspartyl and D-aspartyl residues generated via spontaneous degradation reactions is thought to prevent adverse consequences on protein structure and function [l 11. In the nitrous oxide-treated pig, a model of vitamin B,, deficiency, inhibition of methylation by the inactivation of methionine synthase results in ataxia and hypomethylation of central nervous system proteins [ 11. Demyelination, responsive to treatment with methyl group donors, is a feature of several inherited abnormalities of enzymes in the folate and methylation cycle including 5,lO-methylenetetrahydrofolate reductase [2] and the methionine adenosyltransferase I/III [3] . These disorders prevent the adequate production of the universal methyl group donor, Sadenosylmethionine. LOW levels of cerebrospinal fluid S-adenosylmethionine are found in patients with HIV infection and it has been suggested that it may contribute to the neuropathy and myelopathy of HIV infection [MI.
The aim of this study was to demonstrate the feasibility of measuring the level of protein carboxymethylation in post-mortem human brain tissue as a surrogate measurement of its level at the time of death. It also enabled us to determine the level of protein carboxymethylation in different regions of the human brain.
MATERIALS AND M E T H O D S Patients
The control group consisted of 16 patients (9 males and 7 females) with a mean age of 59k5.1 (range 21-87) years. The brains of control patients were selected for study if a post mortem examination performed by the attending pathologist within 24 h of death was macroscopically normal. Histological analy- Samples of brain were taken from the pole (Brodmann area 10) of the frontal cortex, the parietal lobe beside the central sulcus (Brodmann area 7), the occipital pole (Brodmann area 17), the uncus (Brodmann area 38) of the temporal lobes, caudate nucleus, cortical white matter, cerebellar lobe, pons and the lower medulla/upper spinal cord. Lower medulla/upper spinal cord was obtained in 7 of the 16 patients. Sections of 'cortical tissue' or 'cortex' contained both white and grey matter. Brain and spinal cord samples obtained from the pig and human at post mortem were immediately frozen in liquid nitrogen and stored at -20 "C until homogenization. Freezing in liquid nitrogen had no measurable effect on protein methylation activity. Tissue samples were hand homogenized using a Dounce homogenizer, filtered, divided into aliquots and stored at -20 "C. Tissue samples were subsequently thawed on ice immediately before use.
Determination of protein carboxymethyltransferase activity
Protein carboxymethyltransferase (EC 2.1.1.24) activity of brain samples was assayed as previously Protein carboxymethylation was determined by incubating tissues for 1 or 7 h. Over the first hour of incubation, carboxymethyl group incorporation into protein appeared to increase in an approximately linear fashion (see Results, Figure 2 ). Therefore, the level of protein carboxymethylation after tissue incubations of 1 h was interpreted as an indication of methyltransferase activity. However, a more detailed time course over the first hour of incubation would be needed to determine whether the increase in protein methylation is strictly linear throughout the first hour for each brain tissue sample. A 7 h incubation was chosen as, under the above assay conditions, the incorporation of carboxymethyl groups into brain protein is complete at this time (see Results, Figure 2) . By using saturated amounts of substrate and incubating tissue samples for sufficiently long to ensure maximal incubation of methyl groups, the degree of protein methylation activity reflects the total number of available carboxymethyl group sites contained per milligram of brain protein. For each assay duplicate measurements were performed on each homogenate. A quality control sample consisting of an unused aliquot of the same human brain homogenate was assayed in parallel with test samples to monitor inter-assay variation. The regular use of a quality control sample over a period of approximately 1 year demonstrated the lack of significant variation of protein methylation during prolonged storage at -20 "C.
The reaction was carried out at 37"C, and terminated by the addition of 1 ml of ice-cold trichloroacetic acid (lo%, w/v), followed by 2 0 0~1 of BSA (1 %, w/v) as a protein carrier, and centrifugation in a bench centrifuge at 12000g for 2 min to precipitate protein [ 151. The supernatant was discarded and the pellet washed three more times as above to remove small non-protein molecules which may have been methylated. The pellet was then resuspended by pipetting and vortexing in 1 ml of 1 M borate buffer, pH 11 .O, containing 0.7 YO (v/v) methanol as carrier and left at room temperature for 15 min. The ['HImethanol formed by alkali hydrolysis was extracted five times into 3 ml of toluene/isoamyl alcohol (3:2, v/v) and an aliquot from the upper organic phase quantified by scintillation counting. This extraction procedure removes over 90 YO of the carboxymethylated protein. The results are expressed as units per mg of protein where 1 unit equals 1 pmol of ['Hlmethyl groups incorporated into a mg of protein in 1 h. The methylation result obtained from quantifying the upper phase was referred to as carboxymethylation or 0-methylation. A sample was also taken from the lower inorganic phase after the [3H]methanol had been extracted and quantified by scintillation counting. The radiolabelled proteins in the lower phase were presumed to be mostly N-methylated proteins and the results of analysis of this phase are referred to as protein N-methylation. Protein estimation was determined using the method of Lowry et al. [la] . An endogenous methyl acceptor protein, histone, was used to determine the reproducibility of protein methylation in vitro at different reaction mixture concentrations of brain protein. Twenty-five nanograms of histone, when added to the incubation mixture containing a range of brain protein concentrations, yielded similar amounts of methyl group incorporation into brain protein after subtraction of the methylation activity attributable to histone [ 11. Furthermore, the variation in the level of brain protein methylation in a brain sample was minimal (8.1 % for carboxymethylation and 10 % for N-methylation) when protein concentrations were adjusted by fourfold. Such protein levels were within the range of concentrations of protein in assays of brain samples analysed in the study. These data suggest that within the range of protein levels tested, variation in the level of brain protein added to the incubation mixture did not significantly affect the level of in vitro protein methylation. The pH of the assay was also modified for one experiment (see Results, Figure 3) Results of the levels of brain methylation in different brain regions were expressed as means f S.D. One-way analysis of variance (ANOVA) was used (treatment by subjects ANOVA) as the same subjects were present in each brain region in order to determine whether differences in methylation status existed in different regions of the brain. Where ANOVA detected a significant difference within a brain region, an independent t-test was used to compare differences within each group [19] . All comparisons were regarded as statistically significant if P -= 0.05. Two-sided tests of significance were used for all t-tests.
RESULTS

Sampling variation
The variation in protein carboxymethylation due to sampling within different regions of the brain was determined. The variation noted in the cerebellum (n = 10) was 6.1 % for carboxymethylation and 11 % for N-methylation. Sampling variation in the cortex (n = 9) was 10.5 % for carboxymethylation and 14.5 % for N-methylation. The sampling variation in the cortical white matter (n = 6) was 9.5 YO for carboxymethylation and 16.2 YO for N-methylation.
Stability of protein methylation in the post-mortem pig brain
The pig brain was used to observe changes in protein methylation from the time of death as it is not feasible to analyse post-mortem human brain at this stage. Figure la shows the results of an experiment performed to assess changes in protein methylation in the early post-mortem period. Four pig brains obtained at the abattoir at the time of death were studied. Brains were sampled at this time and samples were snap frozen at the abattoir and stored at -20 "C shortly thereafter. The pig brains were maintained at room temperature and again sampled at 12,18 and 24 h after death. All samples were snap frozen and stored at this time until protein carboxymethylation was determined. As illustrated in Figure la there was no significant difference in the means at any time point for carboxy-(F = 1, P not significant, ANOVA) or Nmethylation (F = 1.6, P not significant, ANOVA).
There was similarly no significant difference in protein carboxymethylation (F = 0.9, P not significant, ANOVA) or N-methylation (F = 1.6, P not significant, ANOVA) in six human post-mortem brain samples. Human tissue samples were obtained at post mortem which occurred 12 h after death. Samples were therefore analysed at the following time points after death; 12 h (time of post mortem), and 18 and 24 h (Figure 1 b) . Similar results were noted in both pig and human brain sections whether they were maintained at room temperature or at 4°C after post mortem (results not shown). Overall, there was no evidence of changes in carboxy-or N-methylation in pig or human brain during the first 24 h after death. This suggests that protein methylation measured in post-mortem brain tissue obtained within 24 h of death gives an accurate estimation of protein methylation at the time of death. Figure 2 illustrates the results of experiments performed to assess the time course of protein methylation of human brain tissue in vitro. Aliquots of brain tissue from six subjects were incubated with [3H-methyl]Sadenosylmethionine for intervals of 30 min (n = 4), 1, 2, 3, 5 and 7 h. There was no measurable in vitro protein methylation if the carboxymethyltransferase assay was performed at room temperature for 1 h, suggesting that methyltransferase activity is markedly reduced to levels below the sensitivity of the assay at room temperature. There was no significant difference in the time course of protein methylation activity at any time point in brain samples from patients who had a rapid onset of death (n = 3) and those who had a prolonged terminal phase before death (n = 3) (results 
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J not shown). Most of the radiolabel is incorporated within 1 h, and the incorporation of radiolabelled Sadenosylmethionine approaches completion after 5 to 7 h. Hence, differences in brain biochemistry which have been noted to occur due to the nature of the agonal phase did not appear to affect the time course of protein methylation in vitro. The level of methyl group incorporation after a 7 h incubation was therefore regarded as the measurement of the 'total' carboxymethylation of brain protein. The kinetics of N-methylation suggested that complete methylation of brain proteins may take longer than 7 h.
Variation in brain protein methylation with p H
Previous studies have demonstrated that protein carboxymethyltransferase activity is optimal at pH 6.4 whereas protein N-methyltransferase activity is optimal at pH 7.2 [17, 18] . To demonstrate pH-related effects, brain tissue samples (six different patient samples) were incubated for 1 h at pH 6.4 as described in the Methods, and separate aliquots of the same tissue samples were incubated under the same conditions except in incubation mixture containing sodium phosphate buffer at pH 7.2. As illustrated in Figure 3 , cortical white matter protein carboxymethylation was significantly greater after 1 h at pH 6.4 compared with pH 7.2 (P < 0.05, Student's paired t-test). Similarly, protein N-methylation was significantly greater at pH 7.2 compared with pH 6.4 (P < 0.05, Student's paired t-test). Table 2 lists the protein methylation results in different regions after incubation of tissues for 1 and 7 h. Statistically significant regional differences were noted in protein carboxymethyl group incorporation after incubation of brain tissues for 1 h (F = 3.67, P < 0.01, ANOVA). Cerebellar tissue incorporated fewer carboxymethyl groups than other tissues apart from the frontal cortex after 1 h incubation (P < 0.05).
Regional variation in carboxymethyl group incorporation in human brain
After 1 h the highest levels of carboxymethyl group incorporation were noted in cortical white matter and cervical cord. The level in cord tissue was statistically significantly higher (P < 0.05) than in all other tissues apart from cortical white matter. Cortical white matter protein carboxymethylation was higher (P < 0.05) than levels in the frontal and occipital cortex.
Significant regional differences were also noted in protein N-methyl group incorporation after incubation of brain tissues for 1 h (F = 4.2, P < 0.05, ANOVA). N-methyl group incorporation was lower (P < 0.05) in the cerebellum compared with the spinal cord, cortical white matter, brain stem, basal ganglia and temporal lobe after 1 h incubation. There were no significant regional differences in N-methyl group incorporation within the cortex. The spinal cord also incorporated more N-methyl groups than other tissues after 1 h incubation; this was only statistically significant (P < 0.05) when compared with the frontal cortex and the cerebellum. The mean cortical methylation values for the different cortical regions were not significantly different after 1 h incubation; hence, determination of protein methylation after 7 h incubation was performed on cortical samples from one representative region of cortex (frontal cortex).
Tissues from the frontal cortex, cortical white matter, basal ganglia, cerebellum, lower medulla/ upper cervical cord and brain stem were incubated for 7 h to determine the total number of availablecarboxymethylation sites in brain proteins isolated from these regions. Significant regional differences in carboxymethylation were noted (F = 13.3, P < 0.01, ANOVA; Table 2 ). As noted after 1 h incubation, after 7 h, protein carboxymethyl group incorporation was significantly less in the cerebellum (P < 0.05) than in the other regions of the brain with the exception of the frontal cortex. Cortical white matter incorporated significantly more carboxymethyl groups than other tissues (P < 0.05) apart from the spinal cord.
Regional differences were also noted in protein Nmethyl group incorporation after 7 h incubation (F = 5.6, P < 0.05, ANOVA) ( Table 2) . Cortical white matter incorporated significantly more N-methyl groups than frontal lobe and basal ganglia (P < 0.05). While cerebellar N-methylation was significantly lower than other tissues after 1 h incubation, this difference was not noted after 7 h.
For each brain region, a comparison of the total protein carboxymethylation after 7 h was made in patients who had a rapid onset of death (n = 6) and those who had a slow onset of death (n = 10). No significant differences were noted for any brain region (results not shown). This suggests that among the patient population studied, differences in agonal phase are not likely to explain the inter-subject variation noted in total in vitro protein methylation.
No significant differences or trends in methyl group incorporation were noted in the brain between different age groups (results not shown), although a larger patient sample would be necessary to determine whether small differences in methylation exist within these subgroups.
DISCUSSION
Experiments described in this paper demonstrate the validity of measuring brain protein methylation on samples of post-mortem human brain. The protein carboxymethyltransferase assay was reproducible on human post-mortem brain tissue both within and between assays. Protein methylation determined in multiple samples obtained from a region of the cortex and cerebellum demonstrated that sampling variation was similar to the extent of intra-assay variation.
Under standard assay conditions, the in vitro protein methylation level obtained after incubation of brain tissue samples for 7 h reflects the total number of available methylation sites on brain protein. Incubation of brain tissue samples for 1 h was used as an approximate estimate of carboxymethyltransferase rate, as protein carboxymethylation activity increases in an approximately linear fashion over the first hour (see Figure 2) .
Proteins isolated from pig and human brain tissues sampled at intervals during the first 24 h after death are similarly carboxymethylated in vitro (Figure 1) . The level of protein methylation in samples of pig brain obtained at the abattoir at the time of death is not significantly different to protein methylation in samples obtained from the same pig brains at subsequent intervals up to 24 h after death (Figure la) . Similar results were obtained using human brain samples obtained at post mortem 12 h after death (Figure 1 b) . The level of brain protein methylation did not alter significantly whether brain was maintained at room temperature or at 4 "C for up to 24 h after death. Hence, within this period temperature fluctuations occurring before autopsy are not likely to alter protein methylation in the human brain. Overall, these results suggest that the level of protein carboxymethylation in a region of post-mortem human brain obtained during this period is representative of protein carboxymethylation at the time of death. Similar stability has been noted for other proteins such as G-proteins and L-isoaspartyl residues in post-mortem brain [20,2 11. The stability of protein methylation in the postmortem human brain will enable further study of the physiological and pathological factors which may affect brain protein methylation in vivo.
The level of protein methylation in the brain of control subjects was notable for the range of values in different subjects within a given region of brain.
Regional variation in protein carboxymethylation was also noted. The control group consisted of an unselected group of patients dying of conditions not thought to influence proteir! methylation. There was no evidence that brain protein methylation was a function of age or sex, although larger numbers of patients would be necessary to rule out whether smaller influences of age or sex exist for protein carboxymethylation.
Protein carboxymethyl group incorporation was least in the cerebellum, intermediate in the cortex and subcortical regions, and highest in the white matter (Table 2 ). Cortical white matter may thus contain relatively undermethylated proteins in vivo compared with other regions of the brain. In myelin, undermethylated proteins have to compete with phospholipids for available methyl groups from S-adenosylmethionine (40% of myelin is phospholipid) [3] . The level of protein methylation in a given brain region could be a marker for the level of methylation of other substrates such as phospholipids and Sadenosylmethionine. These regional differences in methylation may mirror regional differences in sensitivity to hypomethylation resulting from vitamin B,, deficiency, folic acid deficiency, or other diseases disrupting methylation.
Carboxymethyl group incorporation may be lower in the cerebellum than other regions of the brain because there are fewer unmethylated protein methylation sites. In this regard, cerebellar tissue samples were notable for a relative paucity of white matter compared with other regions of the brain. Differences in carboxymethyltransferase activity within the cerebellum are another possible explanation. In this regard, the level of isoprenylated protein methyltransferase is higher in the cerebellum than in other regions of the brain [22] . In so far as is known, this enzyme, initially termed the ras methyltransferase [23] is unique among methyltransferases in its brain distribution. However, interpreting the protein methylation results obtained after 1 h and 7 h incubations of cerebellar tissue suggests that differences in methyltransferase activity are probably not the explanation for these findings. If higher in vivo methyltransferase activity in the cerebellum accounts for the fewer protein methylation sites in vitro when this tissue is incubated for 7 h, one would expect higher, rather than lower, in vitro protein methylation when incubating cerebellar tissue for 1 h.
Several studies have observed that the nature of terminal events such as the rapidity of onset of death may influence neurochemical parameters [ 12, 131 . In this regard, the measurement of pH in post-mortem brain samples provides a useful indicator of agonal status [ 12, 131 . The nature of the agonal state including drug use during terminal care could theoretically influence both the protein methylation activity in vivo and assay behaviour in vitro. Subjects in this series were divided into two groups based on their rapidity of onset of death. This analysis did not reveal any influence of agonal status on brain protein methylation. Despite the lack of such an effect among subjects in this series, additional study of subjects who underwent prolonged agonal phases associated with prolonged coma, hypoxia or renal failure would be necessary to rule out any influence of agonal phase on post-mortem brain protein methylation.
For a given region of brain, there is a wide variation (compared with the mean) in methyl group incorporation into proteins between subjects (Table 2) . Methodological explanations for the inter-subject variation are not likely since similar extent of variation was not evident from measuring variation due to sampling, post-mortem changes, or inter-and intraassay variation. This suggests that physiological influences affect the level of protein methylation in the brain in vivo. The reason for the extent of variability in brain protein methylation is not certain. The level of protein methylation at any given time is predicted to be determined by the overall turnover of brain protein and the activity of protein methyltransferases. The latter is determined by the S-adenosylmethionine/Sadenosylhomocysteine ratio (' methylation ratio ') [24-261. Several physiological factors influence the Sadenosylmethionine/S-adenosylhomocysteine ratio.
Such influences could also affect the overall level of brain protein methylation. S-adenosylhomocysteine levels exist in equilibrium with homocysteine levels [27] which in turn are influenced by the relative activity of the transmethylation and trans-sulphuration pathways [28] . S-adenosylmethionine and S-adenosylhomocysteine levels may vary depending on dietary and other factors which influence the plasma levels of methionine, vitamin B,,, vitamin B, and folic acid. Protein methylation activity is not likely to be simply a surrogate marker of vitamin or S-adenosylmethionine level. This has been shown in the pig brain where Sadenosylmethionine levels did not correlate with protein methylation [29] . For example, in animals, liver Sadenosylmethionine levels vary considerably depending on the dietary methionine intake [28, 30] . Hence, varying methionine intake could influence the degree to which proteins are methylated. A wide range of cerebrospinal fluid S-adenosylmethionine levels is found in man [4] , and is similar to the variation in the central nervous system levels of S-adenosylmethionine that are found in the pig [l] .
It is not known whether the variation in the level of brain protein methylation between subjects is of any functional significance. Deficiency of either folate or vitamin B,, [l] is thought to influence brain function through their effects on the methylation of proteins and other substrates. In one uncontrolled study of healthy elderly individuals, spatial functions were poorer in subjects with 'low normal' compared with 'high' normal serum folate and vitamin B,, levels [31] . This observed beneficial association of 'high normal' folate and vitamin B,, levels may be related to the ability of these vitamins to exert influences on the level of methylation of proteins and other substrates even over their physiological ranges. The physiological influence of the absolute level of 'normal' folate is also evident from studies correlating homocysteine levels with serum folate levels [32] . Selhub et al. [32] demonstrated that plasma folate and vitamin B,, levels are inversely proportional to homocysteine levels even when both folate and vitamin B,, lie within the 'normal range'. It is predicted that homocysteine levels would influence methyltransferase activity since homocysteine exists in equilibrium with S-adenosylhomocysteine. Therefore, evidence exists for the notion that methyltransferase activity and hence protein methylation are influenced by the absolute level of vitamin B,, and folic acid. The clinical identification of adverse effects of 'low normal' folic acid or vitamin B,, levels may be difficult to detect given the subtle neurological presentations of vitamin B,, and folic acid deficiency [33, 34] .
The protein carboxymethyltransferase assay measures overall brain protein methylation activity which is determined by the pooled activity of several types of protein carboxymethyltransferase assays within the brain. Changes limited to a specific protein carboxymethyltransferase would be more appropriately determined by isolation and measurement of that particular enzyme.
In conclusion, this study demonstrates that the level of protein methylation in human brain is stable in the early post-mortem period. This observation will hopefully facilitate the study of physiological and pathological influences on brain protein methylation. The regional distribution of brain protein methylation may mirror the sensitivity of different brain areas to the consequences of altered methylation.
